Shares of CureVac NV rose Thursday after the German biotech company said it was in advanced talks to deliver at least 225 million doses of a potential Covid-19 vaccine to EU member states. CureVac said talks with the EC, the executive arm of the European Union, include an option to …
Read More »Alibaba earnings analysts have cheered ‘V-shaped recovery’, but stock falls
Alibaba Group Holding Ltd. said most of its companies are now back to “healthy growth” as China recovers from the COVID-19 crisis. The Chinese e-commerce giant topped revenue and revenue expectations with its fiscal report in the first quarter beginning Thursday, although its shares were 1.6% off in midday trading. …
Read More »Get your flu in September – before cases start to climb
Reuters With the coronavirus still widespread, it’s time to start thinking seriously about flu, which typically spreads in fall and winter. A major flu outbreak would not only overwhelm hospitals this fall and winter, but also likely overwhelm a person who can contract both at the same time. Doctors do …
Read More »Johns Hopkins scientists studying early side effects of COVID-19 suggest in one way that coronavirus ‘gets a foothold in the body’
It’s a strange side effect. But could it provide clues as to how coronavirus attacks the body? Why do some people with COVID-19 lose their sense of smell? And what can be learned from it? Scientists are examining tissue removed from patients’ noses during surgery, believing they may have discovered …
Read More »Here is the ethical issue for targeting volunteers with COVID-19 to accelerate a vaccine
Despite the urgency of beating COVID-19, health officials may delay the development of an effective vaccine. Authorities in the U.S. and elsewhere have yet to authorize an ethical charge investigation procedure called “trials with human challenge.” Challenge tests deliberately involve volunteers with the disease – which explains the official retention …
Read More »